Journal of Medicinal Chemistry p. 367 - 373 (1991)
Update date:2022-07-29
Topics:
Sliskovic, D. R.
Picard, J. A.
Roark, W. H.
Roth, B. D.
Ferguson, E.
et al.
A series of substituted quinoline mevalonolactones were prepared and evaluated for their ability to inhibit the enzyme HMG-CoA reductase both in vitro and (cholesterol biosynthesis) in vivo.Since previous studies suggested that the 4-(4-fluorophenyl) and 2-(1-methylethyl) substituents afforded optimum potency, attention was focused on variations at position 6 of the quinoline ring.Biological evaluation of a small number of analogues bearing a variety of 6-substituents showed that modification at this position had little effect on potency.Several compounds (8b, 8e, and 11) were identified that showed comparable potency to compaction and mevinolin in both the in vitro and in vivo assays.
View MoreContact:0086 533 2282832
Address:Zibo,Shandong
Shanghai Pengkai Chemical Co.,Ltd
Contact:+86-21-60526671
Address:No.4226 Duzhuang Rd Minhang District Shanghai China
Daqing E-shine Chemical Co.,LTD
Contact:0086-024-31285112
Address:Hongweiyuan area, Ranghulu district
Chemvon Biotechnology Co. Ltd.
website:http://www.chemvon.com
Contact:86-21-58550039;86-21-31268550-8004
Address:Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China
Contact:(1) 206-3550089
Address:5115 NE 8TH PL, Renton, WA 98059 USA
Doi:10.1055/s-0030-1259557
(2011)Doi:10.1080/15421401003608378
(2010)Doi:10.1016/0008-6215(90)80012-R
(1990)Doi:10.1039/c0ob01144d
(2011)Doi:10.1039/jr9370000196
(1937)Doi:10.1021/ja01243a017
(1943)